專 長
.貧血
.血癌
.骨髓移植
.內科癌症
.血液凝固及血小板疾病
現 職
花蓮慈濟醫院血液腫瘤科主治醫師
慈濟大學醫學系腫瘤學科專任助理教授
學 歷
慈濟大學藥理暨毒理學博士
慈濟大學藥理暨毒理學碩士
慈濟大學醫學系
經 歷
花蓮慈濟醫院內科部住院醫師
彰化基督教醫院血液腫瘤科訓練醫師
花蓮慈濟醫院內科部住院總醫師
花蓮慈濟醫院血液腫瘤科住院總醫師
美國 Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School 訪問學者
專科證書
內科專科醫師證書
血液病專科醫師證書
血液及骨髓移植專科醫師證書
台灣臨床腫瘤專科醫師證書
專科學會
台灣內科學會、中華民國血液病學會、中華民國血液及骨髓移植學會、中華民國癌症醫學會
台灣臨床腫瘤學會、中華民國血友病協會
著 作
1. Li CC, Lin CB, Chu SC, Huang WH, Lee JJ, Yang GG, Wang TF, Wu YF*. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma. Medicine (Baltimore). 2020 Jul 17;99(29):e21275. doi: 10.1097/MD.0000000000021275. (Corresponding author)
2. Michael Mazzeffi, Kenichi Tanaka, Yi-Feng Wu, Aijun Zhang, Niharika Kareddy, Emmanuel Tadjou Tito, Peter Rock, Alan D Michelson, Andrew L Frelinger. Platelet surface GPIba, activated GPIIb-IIIa, and P-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patients. Platelets.2020 Dec 7;1-7. doi: 10.1080/09537104.2020.1856360
3. Chih-Lung Shen, Tsung-Cheng Hsieh, Tso-Fu Wang, Wei-Han Huang, Sung-Chao Chu, Yi-Feng Wu*. Designing a scoring system for differential diagnosis from reactive thrombocytosis and essential thrombocytosis. Front Med (Lausanne). 2021 Dec 16; 8:736150. doi: 10.3389/fmed.2021.736150. eCollection 2021. (Corresponding author)
4. Kun-Han Lue, Chun-Hou Huang, Tsung-Cheng Hsieh, Shu-Hsin Liu, Yi-Feng Wu*, Yu-Hung Chen* Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy. Cancers (Basel). 2022 Jan 8;14(2):309. doi: 10.3390/cancers14020309. (Corresponding author)
5. Sheng-Chieh Chou, Yu-Cheng Chang, Chun-kai Liao, Tsung-Chih Chen, Kuo-Jui Sun, Wei-Han Huang, Yi-Feng Wu*. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience. Platelets. 2022 May 19;33(4):531-535. doi: 10.1080/09537104.2022.2042237. Epub 2022 Feb 23. (Corresponding author)
6. Chih-Lung Shen, Yi-Feng Wu*. Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia. Tzu Chi Med J. 2022 Jul 26;34(4):381-387. doi: 10.4103/tcmj.tcmj_117_22. eCollection 2022 Oct-Dec. (Corresponding author)
7. Yi-Feng Wu, Ming-Huei Gu, Chao-Zong Liu, Wei-Han Huang, Sung-Chao Chu, Tso-Fu Wang. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study. PLoS One. 2022 Nov 21;17(11):e0278040. doi: 10.1371/journal.pone.0278040. eCollection 2022.
8. Chih-Lung Shen, Tso-Fu Wang, Chao-Zong Liu, Yi-Feng Wu*. Platelet Activation and Cytokine Release of Interleukin-8 and Interferon-Gamma-Induced Protein 10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection. Vaccines (Basel). 2023 Feb 16;11(2):456. doi: 10.3390/vaccines11020456. (Corresponding author)
9. Yu-Jen Pan, Kuei-Ying Su, Chih-Lung Shen, Yi-Feng Wu*. Correlation of Hematological Indices and Acute-Phase Reactants in Rheumatoid Arthritis Patients on Disease-Modifying Antirheumatic Drugs: A Retrospective Cohort Analysis. J Clin Med. 2023 Dec 11;12(24):7611. doi: 10.3390/jcm12247611. (Corresponding author)